Utility of concentration-effect modeling and simulation in a thorough QT study of losmapimod
Author:
Affiliation:
1. GlaxoSmithKline; King of Prussia PA USA
2. GlaxoSmithKline; Durham NC USA
3. Synergy, Statistics and Programming; Slough Berkshire UK
Funder
GlaxoSmithKline
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference17 articles.
1. Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease;Willette;J Pharmacol Exp Ther,2009
2. Inhibition of p38 mitogen-activated protein kinase improves nitric oxide-mediated vasodilatation and reduces inflammation in hypercholesterolemia;Cheriyan;Circulation,2011
3. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis;Elkhawad;JACC Cardiovasc Imaging,2012
4. Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trial;Newby;Lancet,2014
5. 2005 http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Guideline.pdf
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sex differences in drug-induced QT prolongation;Sex and Cardiac Electrophysiology;2020
2. A Study to Assess the Proarrhythmic Potential of Mirtazapine Using Concentration-QTc (C-QTc) Analysis;Clinical Pharmacology in Drug Development;2018-07-27
3. Evaluating cardiac risk: exposure response analysis in early clinical drug development;Drug, Healthcare and Patient Safety;2018-04
4. Assessing QT/QTc interval prolongation with concentration-QT modeling for Phase I studies: impact of computational platforms, model structures and confidence interval calculation methods;Journal of Pharmacokinetics and Pharmacodynamics;2018-03-19
5. Balancing the Need for Personalization of QT Correction and Generalization of Study Results: Going Beyond Thorough QT Studies;Clinical Drug Investigation;2017-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3